da vigilantbio | Feb 28, 2023
Michael Donovan Ph.D., M.D. joined Vigilant Biosciences in 2015 and serves as the Chief Medical Officer. Dr. Donovan is board-certified in anatomic and clinical pathology and pediatric pathology with extensive experience in designing and implementing clinical studies....
da vigilantbio | Feb 28, 2023
Ben joined Vigilant Biosciences in January 2020 as Chief Commercial Officer to spearhead the organization’s commercial growth globally. Ben has over 25 years experience in healthcare sales and marketing, focused mainly in the areas of medical device, dental, oncology...
da vigilantbio | Feb 28, 2023
Dragan joined Vigilant Biosciences in January 2020 as COO to lead product development and global operations including offshore and domestic manufacturing. Dragan brings 30 years of medical device experience working in various management roles. He holds over 60 US and...
da vigilantbio | Feb 28, 2023
Robert joined Vigilant Biosciences in 2015 as the Chief Financial Officer and VP of Administration. Rob is a former Big–Four CPA with 20+ years of public company and venture–backed private portfolio company experience having worked with companies in e–commerce, health...
da vigilantbio | Feb 28, 2023
Bill joined Vigilant Biosciences in the summer of 2018 as CEO to lead the Company’s transition from a development organization to a successful commercial enterprise. Bill brings over 20 years of experience in management roles. Previously, he served as Chief Commercial...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES